Tianjin Chase Sun Pharmaceutical Co.,Ltd held its Annual General Meeting of 2021 on 21 April 2022 approved the profit distribution proposal for 2021 as cash dividend/10 shares (tax included): CNY 0.40000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 CNY | 0.00% | -3.50% | -15.57% |
Mar. 29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
Mar. 01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.57% | 1.48B | |
+39.50% | 6.23B | |
+5.32% | 3.32B | |
-18.39% | 2.91B | |
-6.41% | 2.42B | |
+42.43% | 1.94B | |
-14.15% | 1.59B | |
-4.27% | 1.58B | |
+38.37% | 1.49B | |
+33.33% | 1.31B |
- Stock Market
- Equities
- 300026 Stock
- News Tianjin Chase Sun Pharmaceutical Co.,Ltd
- Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021